← Back to Search

Behavioral Intervention

Social and Communication Intervention for Autism

N/A
Waitlist Available
Led By Rebecca Landa, PhD, CCC-SLP
Research Sponsored by Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Children must be between the ages of 3 and 6 and enrolled in a participating ASD preschool classroom.
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 9 months into treatment
Awards & highlights

Study Summary

This trial is testing a school-based intervention to improve language and social skills in children with ASD aged 3-6.

Who is the study for?
This trial is for preschoolers aged 3-6 with autism spectrum disorder (ASD) who are enrolled in certain Baltimore County Public School ASD classrooms. Participants must meet specific diagnostic criteria for ASD and have an IQ or Developmental Quotient of at least 40. Preschool educators working in these classrooms can also join.Check my eligibility
What is being tested?
The study is testing the ISC+PRT Intervention, a school-based treatment designed to improve language and social skills in children with ASD. The intervention will be refined through educator feedback and aims to be practical for real-world application.See study design
What are the potential side effects?
Since this is a behavioral intervention focusing on education techniques, traditional medical side effects are not applicable. However, there may be variations in individual responses to the intervention's activities.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My child is between 3 and 6 years old and attends an ASD preschool.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~9 months into treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 9 months into treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in educator instruction to meet fidelity of intervention.
Secondary outcome measures
Change in Baseline Autism Diagnostic Observation Schedule
Change in Baseline Mullen Scales of Early Learning
Change in Child Classroom-based Social Communication Performance
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ISC+PRT InterventionExperimental Treatment1 Intervention
For the duration of at least one school year children will receive 45-90 minutes of intervention in the classroom in an attempt to increase social and communication skills.
Group II: Instruction As UsualActive Control1 Intervention
For the duration of at least one year children will receive the typical classroom instruction

Find a Location

Who is running the clinical trial?

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.Lead Sponsor
88 Previous Clinical Trials
24,238 Total Patients Enrolled
15 Trials studying Autism Spectrum Disorder
2,779 Patients Enrolled for Autism Spectrum Disorder
U.S. Department of EducationFED
86 Previous Clinical Trials
54,032 Total Patients Enrolled
1 Trials studying Autism Spectrum Disorder
103 Patients Enrolled for Autism Spectrum Disorder
Rebecca Landa, PhD, CCC-SLPPrincipal Investigator - Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
7 Previous Clinical Trials
503 Total Patients Enrolled
7 Trials studying Autism Spectrum Disorder
503 Patients Enrolled for Autism Spectrum Disorder

Media Library

ISC+PRT Intervention (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT01591707 — N/A
Autism Spectrum Disorder Research Study Groups: ISC+PRT Intervention, Instruction As Usual
Autism Spectrum Disorder Clinical Trial 2023: ISC+PRT Intervention Highlights & Side Effects. Trial Name: NCT01591707 — N/A
ISC+PRT Intervention (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT01591707 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Am I able to join this trial as a participant?

"Individuals with autism spectrum disorder aged between 3 and 6 are eligible for this trial, which aims to recruit 700 participants."

Answered by AI

Are octogenarians eligible for enrollment in this research program?

"This clinical trial is open to children aged 3-6. There are 213 trials for minors and 41 trials for seniors over 65 years old."

Answered by AI

Are there any vacant spots left for participants in this trial?

"According to clinicaltrials.gov, registration for this trial is currently closed; the research was initially posted on July 1st 2012 and last updated June 1st 2022. Even though this experiment does not yet involve patients, there are still 253 other studies that welcome participants."

Answered by AI
~46 spots leftby Mar 2025